United States · FDA National Drug Code directory
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82619-147_4f67eeb9-5a7a-3693-e063-6394a90a8655
- Product NDC
- 82619-147
- Form
- CAPSULE
- Composition / generic term
- Nitrofurantoin (monohydrate/macrocrystals)
- Labeler
- Creekwood Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260420
- Source listing expiry
- 20271231
Source-listed ingredients
- NITROFURANTOIN — 25 mg/1
- NITROFURANTOIN MONOHYDRATE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (82619-147-01) · 82619-147-01
- 500 CAPSULE in 1 BOTTLE (82619-147-02) · 82619-147-02
- 1 BLISTER PACK in 1 CARTON (82619-147-03) / 14 CAPSULE in 1 BLISTER PACK · 82619-147-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →